Fulcrum Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2019 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Fulcrum Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2019 to Q2 2024.
  • Fulcrum Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 24, 2024 was 62.4M shares, a 0.94% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 62.4M +578K +0.94% Jul 24, 2024 10-Q 2024-07-31
Q1 2024 62.2M +395K +0.64% May 6, 2024 10-Q 2024-05-13
Q3 2023 61.8M +9.77M +18.8% Oct 31, 2023 10-Q 2023-11-07
Q2 2023 61.8M +20.8M +50.8% Jul 27, 2023 10-Q 2023-08-03
Q1 2023 61.8M +20.9M +51.2% Mar 2, 2023 10-K/A 2023-06-26
Q3 2022 52.1M +11.5M +28.4% Nov 1, 2022 10-Q 2022-11-08
Q2 2022 41M +8.3M +25.4% Aug 4, 2022 10-Q 2022-08-11
Q1 2022 40.8M +8.17M +25% May 2, 2022 10-Q 2022-05-09
Q3 2021 40.5M +13.1M +47.7% Oct 28, 2021 10-Q 2021-11-04
Q2 2021 32.7M +5.26M +19.1% Aug 3, 2021 10-Q 2021-08-10
Q1 2021 32.7M +9.32M +39.9% Apr 29, 2021 10-Q 2021-05-06
Q3 2020 27.5M +4.12M +17.7% Nov 4, 2020 10-Q 2020-11-10
Q2 2020 27.5M Aug 4, 2020 10-Q 2020-08-11
Q1 2020 23.4M Feb 28, 2020 10-K 2020-03-05
Q3 2019 23.3M Aug 23, 2019 10-Q 2019-08-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.